A recent study demonstrated that treatment of AD mice with two PERK inhibitors, trazodone and dibenzoylmethane, effectively restored memory impairment, abrogated neurological signs, prevented neurodegeneration, and prolonged survival (208). The gene discussed is EIF2AK3; the disease is Alzheimer disease.